Pharmacokinetics of verapamil in diabetic rats induced by combination of high-fat diet and streptozotocin injection

被引：33

作者：

Chen, G. M. ^{[1
]}

Hu, N. ^{[1
]}

Liu, L. ^{[1
]}

Xie, S. S. ^{[1
]}

Wang, P. ^{[1
]}

Li, J. ^{[1
]}

Xie, L. ^{[1
]}

Wang, G. J. ^{[1
]}

Liu, X. D. ^{[1
]}

机构：

[1] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China

来源：

XENOBIOTICA | 2011年 / 41卷 / 06期

基金：

美国国家科学基金会;

关键词：

Diabetes; verapamil; CYP3A; pharmacokinetics; insulin resistance; GLUCOSE-TOLERANCE; CYTOCHROME-P450; 2E1; HOMEOSTASIS MODEL; MELLITUS; INSULIN; METABOLISM; ANTIPYRINE; INCREASES; DIAZINON; ENZYMES;

D O I：

10.3109/00498254.2011.558933

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. The aim of this study was to investigate effects of type 2 diabetes on the pharmacokinetics of verapamil after intravenous administration. 2. Diabetes mellitus (DM) rats were induced by combination of high-fat diet (HFD) and streptozotocin. Plasma concentrations of verapamil in DM rats, rats fed with HFD, and control (CON) rats were measured after intravenous administration of 1 mg/kg verapamil and corresponding pharmacokinetic parameters were estimated. Area under the plasma concentration in DM rats was significantly smaller than that in CON rats. 3. In vitro microsomal study showed that intrinsic clearance of verapamil in DM rats was significantly higher than those in CON rats. Compared to CON rats, higher intrinsic clearance was also observed in HFD rats. Western blot results demonstrated higher levels of CYP3A2 in DM and HFD rats, which was in line to activity of CYP3A. 4. All the results gave a conclusion that diabetes may enhance metabolism of verapamil in rat, and the enhancement may partly result from induction of CYP3A.

引用

页码：494 / 500

页数：7

共 31 条

[1] BENEFICIAL-EFFECTS OF VERAPAMIL IN DIABETIC CARDIOMYOPATHY [J].

AFZAL, N ;

GANGULY, PK ;

DHALLA, KS ;

PIERCE, GN ;

SINGAL, PK ;

DHALLA, NS .

DIABETES, 1988, 37 (07) :936-942

[2]

ANDERSSON DEH, 1981, ACTA MED SCAND, V210, P27

[3] Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].

Bonora, E ;

Saggiani, F ;

Targher, G ;

Zenere, MB ;

Alberiche, M ;

Monauni, T ;

Bonadonna, RC ;

Muggeo, M .

DIABETES CARE, 2000, 23 (01) :57-63

[4]

BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[5] Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride [J].

Choi, JS ;

Burm, JP .

ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (04) :483-487

[6] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[7] THE 24-HOUR AMBULATORY BLOOD-PRESSURE PROFILE WITH VERAPAMIL [J].

GOULD, BA ;

MANN, S ;

KIESO, H ;

SUBRAMANIAN, VB ;

RAFTERY, EB .

CIRCULATION, 1982, 65 (01) :22-27

[8]

HU N, 2010, DRUG METAB IN PRESS

[9] Marked inhibition of hepatic cytochrome P450 activity in cholesterol-induced atherosclerosis in rabbits [J].

Irizar, A ;

Ioannides, C .

TOXICOLOGY, 1998, 126 (03) :179-193

[10] Increase in P-glycoprotein accompanied by activation of protein kinase Cα and NF-κB p65 in the livers of rats with streptozotocin-induced diabetes [J].

Kameyama, Natsumi ;

Arisawa, Sakiko ;

Ueyama, Jun ;

Kagota, Satomi ;

Shinozuka, Kazumasa ;

Hattori, Ai ;

Tatsumi, Yasuaki ;

Hayashi, Hisao ;

Takagi, Kenji ;

Wakusawa, Shinya .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2008, 1782 (05) :355-360

← 1 2 3 4 →